RI-820

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameRI-820
Drug Alias Nameprotein-based peripheral neurodegenerative disease protectant (Rinat)RI-820
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsMuscular Atrophy, SpinalAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRinat-Pfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRinat-Pfizer Inc
Active IndicationsN/A
Inactive IndicationsMuscular Atrophy, SpinalAmyotrophic Lateral Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A